Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$191.51 - $216.16 $44.2 Million - $49.9 Million
-231,000 Reduced 35.27%
424,000 $90 Million
Q2 2023

Aug 01, 2023

BUY
$187.64 - $206.25 $123 Million - $135 Million
655,000 New
655,000 $126 Million
Q4 2021

Jan 21, 2022

SELL
$142.57 - $190.86 $2.27 Million - $3.04 Million
-15,941 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$142.45 - $169.82 $2.27 Million - $2.71 Million
15,941 New
15,941 $2.71 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Segantii Capital Management LTD Portfolio

Follow Segantii Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.